CDTX vs L · rev $1.3M vs P/E 14, rev $18.45B
Cidara Therapeutics Inc (CDTX) versus Loews Corp (L) — a side-by-side from cached financials, not a winner call.
Cidara Therapeutics Inc (CDTX) is a biotechnology company listed on US.
Loews Corp (L) is a insurance - property & casualty company listed on NYSE.
Latest reported CDTX revenue for 2024-12-31 was $1.3M. Net income was -$169.8M. Revenue was down 94.5% from 2023-12-31 to 2024-12-31. CDTX currently screens at market cap $6.96B.
Latest reported L revenue for 2025-12-31 was $18.45B. Net income was $1.67B. Revenue was up 5.4% from 2024-12-31 to 2025-12-31. L currently screens at market cap $22.36B and trailing P/E 13.8.
CDTX currently screens at market cap $6.96B. L currently screens at market cap $22.36B and trailing P/E 13.8.
Not investment advice. Open the CDTX and L stock pages for the full models.
Not investment advice.